NCT07034859 2025-06-24
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
National Taiwan University Hospital
Phase 4 Enrolling by invitation
Clinical Trials
5 trialsNCT02288962 2025-06-08
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
St. Olavs Hospital
Phase 3 Active not recruiting
NCT03457389 2020-03-18
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
Phase NA Unknown
NCT03271918 2017-09-07
Cabergoline in Nonfunctioning Pituitary Adenomas
University of Sao Paulo General Hospital
Phase 3 Completed
NCT00889525 2009-04-29
Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Seth Gordhandas Sunderdas Medical College
Phase 3 Completed